Guardion Health Sciences Announces Financial Results for the Year Ended December 31, 2022

Author's Avatar
Apr 17, 2023

Viactiv® Product Line Generated Net Revenues of approximately $10.6 Million or 96% of Net Revenues for the Year Ended December 31, 2022